EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Aeruginosin 525 (AER525) from Cyanobacterium Aphanizomenon Sp. (KUCC C2): A New Serine Proteases Inhibitor

Donata Overlingė, Marta Cegłowska iD, Robert Konkel iD, Hanna Mazur-Marzec iD

Marine Drugs · 2024

DOI: 10.3390/md22110506 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Marine Drugs, 2024. Verfasst von Donata Overlingė und 3 weiteren Autor:innen. Beteiligte Einrichtung: Marine Research Institute, Klaipėda University, Universiteto av. 17, LT-92294 Klaipėda, Lithuania. Hauptthemen laut MEDLINE: Serine Proteinase Inhibitors, Aphanizomenon. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Lithuanian National Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aeruginosins (AERs) are one of the most common classes of cyanobacterial peptides synthesised through a hybrid non-ribosomal peptide synthase/polyketide synthase pathway. They have been found in Microcystis, Nodularia spumigena, Oscillatoria/Plantothrix, and Nostoc. The presence of AER in Aphanizomenon isolated from the Curonian Lagoon was reported for the first time in our previous work. Here, the structure of aeruginosin 525 (AER525), isolated from Aphanizomenon sp. KUCC C2, was characterised based on high-resolution mass spectrometry. This new AER variant shows potent activity against thrombin. It also inhibits trypsin and carboxypeptidase A but has no effect on elastase and chymotrypsin. In terms of the N-terminal residue and biological activity, AER525 displaces some similarity to dysinosins, which belongs to the most potent inhibitors of thrombin among AERs. The findings underline the potential of AER525 as a new anticoagulant agent.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Serine Proteinase InhibitorsAphanizomenonThrombinAnticoagulantsCyanobacteria

Stichwörter der Autor:innen

bioactive peptidesenzyme inhibitionhigh-resolution mass spectroscopy

Substanzen

Serine Proteinase InhibitorsThrombinAnticoagulants

Autor:innen und Institutionen

  • Marine Research Institute, Klaipėda University, Universiteto av. 17, LT-92294 Klaipėda, Lithuania.
  • Institute of Oceanology, Polish Academy of Sciences, Powstańców Warszawy 55, PL-81712 Sopot, Poland.
  • Department of Marine Biology and Biotechnology, University of Gdańsk, M. J. Piłsudskiego 46, PL-81378 Gdynia, Poland.

ORCID-Profile: Marta Cegłowska, Robert Konkel, Hanna Mazur-Marzec

Förderung

  • Lithuanian National Science Foundation

Zitieren

APA

Overlingė, D., Cegłowska, M., Konkel, R., & Mazur-Marzec, H. (2024). Aeruginosin 525 (AER525) from Cyanobacterium Aphanizomenon Sp. (KUCC C2): A New Serine Proteases Inhibitor. Marine Drugs. https://doi.org/10.3390/md22110506

Vancouver

Overlingė D, Cegłowska M, Konkel R, Mazur-Marzec H. Aeruginosin 525 (AER525) from Cyanobacterium Aphanizomenon Sp. (KUCC C2): A New Serine Proteases Inhibitor. Marine Drugs. 2024. doi:10.3390/md22110506

BibTeX
@article{Overling2024,
  author = {Overlingė, Donata and Cegłowska, Marta and Konkel, Robert and Mazur-Marzec, Hanna},
  title = {Aeruginosin 525 (AER525) from Cyanobacterium Aphanizomenon Sp. (KUCC C2): A New Serine Proteases Inhibitor},
  journal = {Marine Drugs},
  year = {2024},
  doi = {10.3390/md22110506}
}
Kostenlos starten →